Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial

Stewart B. Harris; Győző Kocsis; Rudolf Prager; Terry Ridge; Keval Chandarana; Natalie Halladin; Serge Jabbour

doi:10.1111/dom.12892

Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12892 ◽

2017 ◽

Vol 19 (6) ◽

pp. 858-865 ◽

Cited By ~ 35

Author(s):

Stewart B. Harris ◽

Győző Kocsis ◽

Rudolf Prager ◽

Terry Ridge ◽

Keval Chandarana ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Safety And Efficacy ◽

Oral Antidiabetic

Download Full-text

Maintenance of Glycemic Control with Liraglutide versus Oral Antidiabetic Drugs as Add‐on Therapies in Patients with Type 2 Diabetes Uncontrolled with Metformin Alone: A Randomized Clinical Trial in Primary Care ( LIRA‐PRIME )

Diabetes Obesity and Metabolism ◽

10.1111/dom.14566 ◽

2021 ◽

Author(s):

Jeff Unger ◽

Dale C. Allison ◽

Margit Kaltoft ◽

Kavitha Lakkole ◽

Jayant K. Panda ◽

...

Keyword(s):

Type 2 Diabetes ◽

Primary Care ◽

Clinical Trial ◽

Glycemic Control ◽

Randomized Clinical Trial ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial

Diabetes Care ◽

10.2337/dc19-2452 ◽

2020 ◽

Vol 43 (6) ◽

pp. 1249-1257

Author(s):

Hirotaka Watada ◽

Akane Takami ◽

Robert Spranger ◽

Atsushi Amano ◽

Yasuhiro Hashimoto ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Glargine ◽

Randomized Clinical Trial ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program

Diabetes Therapy ◽

10.1007/s13300-017-0252-9 ◽

2017 ◽

Vol 8 (3) ◽

pp. 673-682 ◽

Cited By ~ 1

Author(s):

Kamlesh Khunti ◽

Viswanathan Mohan ◽

Sunil M. Jain ◽

Trine Welløv Boesgaard ◽

Kamilla Begtrup ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Basal Insulin ◽

Antidiabetic Drugs ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic ◽

Clinical Trial Program

Download Full-text

Safety and efficacy of once‐weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13218 ◽

2018 ◽

Vol 20 (5) ◽

pp. 1202-1212 ◽

Cited By ~ 31

Author(s):

Kohei Kaku ◽

Yuichiro Yamada ◽

Hirotaka Watada ◽

Atsuko Abiko ◽

Tomoyuki Nishida ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Trial ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Japanese People ◽

Safety And Efficacy ◽

Oral Antidiabetic

Download Full-text

Abstract #292 Efficacy of Hydroxychloroquine when added in Subjects with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Basal Insulin and Two Other Oral Antidiabetic Drugs

Endocrine Practice ◽

10.1016/s1530-891x(20)46636-4 ◽

2019 ◽

Vol 25 ◽

pp. 119-120

Author(s):

Arjun Baidya ◽

Ajay Chhabra

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Basal Insulin ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

2224-PUB: Comparative Effectiveness of Second-Line Initiation of Basal Insulin Therapy vs. Oral Antidiabetic Drugs Added to Metformin among Patients with Type 2 Diabetes in Taiwan

Diabetes ◽

10.2337/db19-2224-pub ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 2224-PUB

Author(s):

PIN-HAO CHEN ◽

SHIHCHEN KUO ◽

HUANG-TZ OU

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Comparative Effectiveness ◽

Basal Insulin ◽

Antidiabetic Drugs ◽

Second Line ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Efficacy and safety of insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP‐L randomized clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14005 ◽

2020 ◽

Vol 22 (S4) ◽

pp. 3-13 ◽

Cited By ~ 3

Author(s):

Hideaki Kaneto ◽

Akane Takami ◽

Robert Spranger ◽

Atsushi Amano ◽

Daisuke Watanabe ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Type 2 Diabetes Mellitus ◽

Fixed Ratio ◽

Japanese Patients ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text

Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

Diabetes & Metabolism ◽

10.1016/j.diabet.2019.101117 ◽

2020 ◽

Vol 46 (2) ◽

pp. 100-109 ◽

Cited By ~ 26

Author(s):

M.S. Capehorn ◽

A.-M. Catarig ◽

J.K. Furberg ◽

A. Janez ◽

H.C. Price ◽

...

Keyword(s):

Type 2 Diabetes ◽

Antidiabetic Drugs ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Once Daily ◽

Oral Antidiabetic

Download Full-text

Insulin glargine in combination with oral antidiabetic drugs as a cost-equivalent alternative to conventional insulin therapy in type 2 diabetes mellitus

Wiener klinische Wochenschrift ◽

10.1007/s00508-005-0429-5 ◽

2005 ◽

Vol 117 (17) ◽

pp. 593-598 ◽

Cited By ~ 7

Author(s):

Monika Lechleitner ◽

Michael Roden ◽

Eva Haehling ◽

Markus Mueller

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Insulin Therapy ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Conventional Insulin Therapy ◽

Oral Antidiabetic

Download Full-text

Albiglutide, a weekly GLP-1 receptor agonist, improves glycemic parameters in Japanese patients with type 2 diabetes over 1 year when added to single oral antidiabetic drugs

Current Medical Research and Opinion ◽

10.1080/03007995.2016.1261817 ◽

2016 ◽

Vol 33 (3) ◽

pp. 431-438 ◽

Cited By ~ 3

Author(s):

Inaha Okuda ◽

Timothy H. Wilson ◽

Lin Yue ◽

Hiromu Nakajima ◽

Molly C. Carr ◽

...

Keyword(s):

Type 2 Diabetes ◽

Receptor Agonist ◽

Japanese Patients ◽

Antidiabetic Drugs ◽

Oral Antidiabetic Drugs ◽

Oral Antidiabetic

Download Full-text